Skip to main content

Table 1 Characteristics of patients

From: Propofol TCI or sevoflurane anesthesia without muscle relaxant for thoracoscopic thymectomy in myasthenia gravis patients: a prospective, observational study

 

Group P

(n = 45)

Group S

(n = 45)

p value

Gender (male/female)

20/25

21/24

0.832α

Age – years (mean ± SD)

43.2 ± 15.1

40.7 ± 11.9

0.862β

Body weight – kg (mean ± SD)

56.7 ± 7.9

53.3 ± 9.4

0.440β

Height – m (mean ± SD)

161.6 ± 6.9

161.4 ± 6.8

0.951β

MGFA classification – no. (%)

 I

15 (33)

13 (28)

0.109α

 IIa

27 (60)

22 (49)

 IIb

3 (7)

10 (22)

Disease duration-months (mean, range)

34.3 (1–96)

28.8 (1–108)

0.549γ

Thyroma (yes/no)

41/4

37/8

0.353δ

Pre-operative treatment

 Pyridostigmine – no. dosage-mg.day−1 (mean, range)

45 263 (60–600)

45 224 (60–540)

0.226β

 Prednisone – no

5

10

0.157α

 Plasmapheresis – no

6

7

0.764α

  1. MGFA Myasthenia Gravis Foundation of America
  2. αChi-squared test
  3. βStudent’s t test
  4. γMann‒Whitney U test
  5. δFisher’s exact test